# Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)

Study · id `cardio:ct-nct07412626` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07412626](<https://clinicaltrials.gov/study/NCT07412626>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07412626

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 135 participants.

## Technical summary

Registry record NCT07412626. Randomized; no masking; primary purpose supportive care. Start 2026-04-01 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 135 participants (planned count; ClinicalTrials.gov record NCT07412626, source copy `cardio:ctgov-nct07412626-2026-02-17`, retrieved 2026-10-26)
- Planned start: 2026-04-01 (anticipated) (ClinicalTrials.gov record NCT07412626, source copy `cardio:ctgov-nct07412626-2026-02-17`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07412626, source copy `cardio:ctgov-nct07412626-2026-02-17`, retrieved 2026-10-26)
- Completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT07412626, source copy `cardio:ctgov-nct07412626-2026-02-17`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07412626, source copy `cardio:ctgov-nct07412626-2026-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07412626-2026-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)
- Acronym: Heartlogic ISR
- Condition: Congestive Heart Failure Chronic
- Condition: Low Ejection Fraction
- Intervention (Device): Heartlogic Diagnostic Tool Threshold Change
- Intervention (Device): Heartlogic Diagnostic Tool Unchanged Threshold
- Lead sponsor: Robert Pickett
- Lead sponsor class: INDUSTRY
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY
- Collaborator: Ascension Health
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: db7468263d17a8757c1d110354dac11978565a8f98579fad8b3c7feea96779b0
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
